12.01.09
Phase A | |
Dehymuls PGPH (Cognis) (Polyglyceryl-2 dipoly hydroxystearate) | 5.00 |
Monomuls 90-O 18 (Cognis) (Glyceryl oleate) | 0.50 |
Finsolv TN (Finetex) (C12-15 alkyl benzoate) | 6.00 |
Myritol 318 (Cognis) (Caprylic/capric triglyceride) | 6.00 |
Isopropyl myristate (Cognis) | 8.00 |
Myritol 331 (Cognis) (Cocoglycerides) | 6.00 |
Lanette O (Cognis) (Cetearyl alcohol) | 1.00 |
Parsol TX (DSM) (Titanium dioxide & dimethicone & silica) | 10.00 |
Euxyl K 300 (Schu00fclke & Mayr) (Phenoxyethanol & methylparaben & propylparaben & ethylparaben & butylparaben & isobutylparaben) | 0.80 |
Z-Cote HP1 (BASF) (Zinc oxide (and) triethoxycaprylylsilane) | 5.00 |
Dow Corning 345 (Dow Corning) (Fluid cyclopentasiloxane & cyclohexasiloxane) | 1.00 |
Magnesiumsulfat, Heptahydrat (Merck) (Magnesium sulfate, heptahydrate) | 1.00 |
Water dem. | 39.70 |
Phase B | |
1,3-Butylenglykol (Merck) (Butylene glycol) | 10.00 |
Procedure | |
Heat phase A to 85°C while stirring. Heat part B to 80°C and add to phase A while stirring and homogenizing the emulsion. Cool down further to room temperature. It is highly recommended to remove oxygen as much as possible by using vacuum while producing the product. | |
Properties | |
Viscosity—41200 cps (Brookfield, RV5,10 rpm); SPF in vivo—24.9 In vitro UVAPF (Colipa 2007)—Not measurable; PFA—7.4. Notes: For U.S. AP, LA EU. | |
More Information | |
DSM Nutritional Products, Tel: (973) 257-8501; Website: www.nutraaccess.com |